Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2.
ABSTRACTIncreasing spread by SARS-CoV-2 Omicron variants challenges existing vaccines and broadly reactive neutralizing antibodies (bNAbs) against COVID-19. Here we determine the diversity, potency, breadth and structural insights of bNAbs derived from memory B cells of BNT162b2-vaccinee after homogeneous Omicron BA.1 breakthrough infection. The infection activates diverse memory B cell clonotypes ... for generating potent class I/II and III bNAbs with new epitopes mapped to the receptor-binding domain (RBD). The top eight bNAbs neutralize wildtype and BA.1 potently but display divergent IgH/IgL sequences and neuralization profiles against other variants of concern (VOCs). Two of them (P2D9 and P3E6) belonging to class III NAbs display comparable potency against BA.4/BA.5, although structural analysis reveals distinct modes of action. P3E6 neutralizes all variants tested through a unique bivalent interaction with two RBDs. Our findings provide new insights into hybrid immunity on BNT162b2-induced diverse memory B cells in response to Omicron breakthrough infection for generating diverse bNAbs with distinct structural basis.
Mesh Terms:
Adaptive Immunity, Antibodies, Neutralizing, Antibodies, Viral, BNT162 Vaccine, Breakthrough Infections, Broadly Neutralizing Antibodies, COVID-19, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Adaptive Immunity, Antibodies, Neutralizing, Antibodies, Viral, BNT162 Vaccine, Breakthrough Infections, Broadly Neutralizing Antibodies, COVID-19, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Emerg Microbes Infect
Date: Dec. 01, 2023
PubMed ID: 36354024
View in: Pubmed Google Scholar
Download Curated Data For This Publication
247444
Switch View:
- Interactions 1